Screener
Tyra Biosciences, Inc. TYRA Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Tyra Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Tyra Biosciences, Inc.’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 8:03 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-220645
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Property and equipment, net | 1,215 | 1,314 |
| Right-of-use assets | 5,443 | 5,573 |
| Other long-term assets | 9,885 | 9,272 |
| Total assets | $412,040 | $282,609 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $3,642 | $1,178 |
| Lease liabilities, current | 488 | 472 |
Item 1. Condensed Financial Statements
FAQ
- What is Tyra Biosciences, Inc.'s total assets?
- Tyra Biosciences, Inc. (TYRA) reported total assets of $412.04M in Q1 2026.
- How has Tyra Biosciences, Inc.'s total assets changed year-over-year?
- Tyra Biosciences, Inc.'s total assets increased by 20.0% year-over-year, from $343.48M to $412.04M.
- What is the long-term trend for Tyra Biosciences, Inc.'s total assets?
- Over 5 years (2020 to 2025), Tyra Biosciences, Inc.'s total assets has grown at a 77.6% compound annual growth rate (CAGR), from $16.01M to $282.61M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Tyra Biosciences, Inc.'s total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude